Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 15, 1985 - Issue 6
50
Views
71
CrossRef citations to date
0
Altmetric
Original Article

The interaction of representative members from two classes of antimycotics—the azoles and the allylamines—with cytochromes P-450 in steroidogenic tissues and liver

Pages 529-546 | Received 24 Jul 1984, Published online: 30 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Jason G Newland & Susan M Abdel-Rahman. (2009) Update on terbinafine with a focus on dermatophytoses. Clinical, Cosmetic and Investigational Dermatology 2, pages 49-63.
Read now
Inge Schuster & Rita Bernhardt. (2007) Inhibition of Cytochromes P450: Existing and New Promising Therapeutic Targets. Drug Metabolism Reviews 39:2-3, pages 481-499.
Read now
NS Ryder. (1992) Selective action of allylamines and its therapeutic implications. Journal of Dermatological Treatment 3:sup1, pages 3-7.
Read now
Rc Savin. (1990) Terbinafine (Lamisil) versus griseofulvin in moccasin type tinea pedis. Journal of Dermatological Treatment 1:sup2, pages 43-46.
Read now
Dj Back & Jf Tija. (1990) Azoles and allylamines: the clinical implications of interaction with cytochrome P-450 enzymes. Journal of Dermatological Treatment 1:sup2, pages 11-13.
Read now
I Schuster & Ns Ryder. (1990) Allylamines — Mode and selectivity of action compared to azole antifungals and biological fate in mammalian organisms. Journal of Dermatological Treatment 1:sup2, pages 7-9.
Read now
K. Lavrijsen, J. van Houdt, D. Thijs, W. Meuldermans & J. Heykants. (1987) Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsornes. Xenobiotica 17:1, pages 45-57.
Read now
A. D. Rodrigues, D. F. V. Lewis, C. Ioannides & D. V. Parke. (1987) Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450. Xenobiotica 17:11, pages 1315-1327.
Read now

Articles from other publishers (61)

Anilkumar B. Pillai, Jyothilaksmi V. Nair, Nishant Kumar Gupta & Swati Gupta. (2015) Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery. Archives of Dermatological Research 307:7, pages 625-633.
Crossref
Alberto De Petris, Maria Elisa Crestoni, Adele Pirolli, Carme Rovira, Javier Iglesias-Fernández, Barbara Chiavarino, Rino Ragno & Simonetta Fornarini. (2015) Binding of azole drugs to heme: A combined MS/MS and computational approach. Polyhedron 90, pages 245-251.
Crossref
Damien Baudiffier, Nathalie Hinfray, Catherine Ravaud, Nicolas Creusot, Edith Chadili, Jean-Marc Porcher, Rüdiger W. Schulz & François Brion. (2013) Effect of in vivo chronic exposure to clotrimazole on zebrafish testis function. Environmental Science and Pollution Research 20:5, pages 2747-2760.
Crossref
Damien Baudiffier, Nathalie Hinfray, Mélanie Vosges, Nicolas Creusot, Edith Chadili, Jean-Marc Porcher, Rüdiger W. Schulz & François Brion. (2012) A critical role of follicle-stimulating hormone (Fsh) in mediating the effect of clotrimazole on testicular steroidogenesis in adult zebrafish. Toxicology 298:1-3, pages 30-39.
Crossref
Nathalie Hinfray, Damien Baudiffier, Marcelo C. Leal, Jean-Marc Porcher, Sélim Aït-Aïssa, Florence Le Gac, Rüdiger W. Schulz & François Brion. (2011) Characterization of testicular expression of P450 17α-hydroxylase, 17,20-lyase in zebrafish and its perturbation by the pharmaceutical fungicide clotrimazole. General and Comparative Endocrinology 174:3, pages 309-317.
Crossref
Dalia A. Hamdy & Dion R. Brocks. (2011) Effect of hyperlipidemia on ketoconazole–midazolam drug–drug interaction in rat. Journal of Pharmaceutical Sciences 100:11, pages 4986-4992.
Crossref
J. Ross Buchan, Je-Hyun Yoon & Roy Parker. (2011) Stress-specific composition, assembly and kinetics of stress granules in Saccharomyces cerevisiae . Journal of Cell Science 124:2, pages 228-239.
Crossref
Peter G. Pappas. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology 113 119 .
Michael PfallerRana Traboulsi & Mahmoud Ghannoum. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 1763 1771 .
Dalia A. Hamdy & Dion R. Brocks. (2008) Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate. Chirality 21:7, pages 704-712.
Crossref
Thérèse Sergent, Isabelle Dupont, Coralie Jassogne, Laurence Ribonnet, Edwige van der Heiden, Marie-Louise Scippo, Marc Muller, Dan McAlister, Luc Pussemier, Yvan Larondelle & Yves-Jacques Schneider. (2009) CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells—Comparison with other conazole pesticides. Toxicology Letters 184:3, pages 159-168.
Crossref
Philip R. Balding, Cristina S. Porro, Kirsty J. McLean, Michael J. Sutcliffe, Jean-Didier Maréchal, Andrew W. Munro & Sam P. de Visser. (2008) How Do Azoles Inhibit Cytochrome P450 Enzymes? A Density Functional Study. The Journal of Physical Chemistry A 112:50, pages 12911-12918.
Crossref
Joseph MeletiadisStephen Chanock & Thomas J Walsh. (2008) Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. Pharmacogenomics 9:5, pages 561-584.
Crossref
Malcolm J.M. Darkes, Lesley J. Scott & Karen L. Goa. (2003) Terbinafine. American Journal of Clinical Dermatology 4:1, pages 39-65.
Crossref
Inge Schuster, Helmut Egger, Gerda Herzig, G. Satyanarayana Reddy & Georg Vorisek. 2003. Vitamin D Analogs in Cancer Prevention and Therapy. Vitamin D Analogs in Cancer Prevention and Therapy 169 188 .
Katsumi Morishita, Hiroshi Okumura, Norio Ito & Nobuo Takahashi. (2001) Primary culture system of adrenocortical cells from dogs to evaluate direct effects of chemicals on steroidogenesis. Toxicology 165:2-3, pages 171-178.
Crossref
I Schuster, H Egger, D Bikle, G Herzig, G.S Reddy, A Stuetz, P Stuetz & G Vorisek. (2001) Selective inhibition of vitamin D hydroxylases in human keratinocytes11Abbreviations: VD: vitamin D3; 25(OH)D3: 25-hydroxyvitamin D3; 3H-25(OH)D3: [26,27n-3H] 25-hydroxyvitamin D3; 1α,25(OH)2D3: 1α,25-dihydroxyvitamin D3; 1α,25(OH)2-3epi-D3: 1α,25-dihydroxyvitamin-3-epi-D3; 1α,24(R),25(OH)3D3: 1α,24(R),25-trihydroxyvitamin D3, 1α,25(OH)2-24oxo-D3: 1α,25-dihydroxy-24oxo-vitamin D3; 1α,23(S),25(OH)3-24oxo-D3: 1α,23(S),25-trihydroxy-24oxo-vitamin D3; calcitroic acid: 1α-hydroxy-23-carboxy-24,25,26,27-tetranorvitamin D3; CYP: cytochrome P450; 1α-hydroxylase: 25-hydroxyvitamin D3-1α-hydroxylase; 24-hydroxylase (CYP24), 1α,25-hydroxyvitamin D3-24-hydroxylase; PHK, primary human keratinocytes; KGM: keratinocyte growth medium; HPLC, high performance liquid chromatography; IC50: half-maximum inhibitor concentration; SD: standard deviation.. Steroids 66:3-5, pages 409-422.
Crossref
Sanjeev Jain & Virendra N. Sehgal. (2001) Terbinafine, a unique oral antifungal: current perceptions. International Journal of Dermatology 39:6, pages 412-423.
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2000) Effects of the Antifungal Agents on Oxidative Drug Metabolism. Clinical Pharmacokinetics 38:2, pages 111-180.
Crossref
Aditya K. Gupta, H.Irving Katz & Neil H. Shear. (1999) Drug interactions with itraconazole, fluconazole, and terbinafine and their management. Journal of the American Academy of Dermatology 41:2, pages 237-249.
Crossref
Eric F. Trépanier, Anne N. Nafziger, Gregory L. Kearns, Angela D. M. Kashuba & Guy W. Amsden. (2013) Absence of Effect of Terbinafine on the Activity of CYP1A2, NAT‐2, and Xanthine Oxidase. The Journal of Clinical Pharmacology 38:5, pages 424-428.
Crossref
Eric F. Trépanier, Anne N. Nafziger & Guy W. Amsden. (1998) Effect of Terbinafine on Theophylline Pharmacokinetics in Healthy Volunteers. Antimicrobial Agents and Chemotherapy 42:3, pages 695-697.
Crossref
Aditya K. Gupta & Neil H. Shear. (1997) Terbinafine: An update. Journal of the American Academy of Dermatology 37:6, pages 979-988.
Crossref
Donald L. Greer, Jonathan Weiss, David A. Rodriguez, Adelaide A. Hebert & James M. Swinehart. (1997) A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. Journal of the American Academy of Dermatology 37:2, pages 231-235.
Crossref
Susan M Abdel-Rahman & Milap C Nahata. (2017) Oral Terbinafine: A New Antifungal Agent. Annals of Pharmacotherapy 31:4, pages 445-456.
Crossref
Eduardo Tschen, Boni Elewski, David C. Gorsulowsky & David M. Pariser. (1997) Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. Journal of the American Academy of Dermatology 36:2, pages S9-S14.
Crossref
G. F. Schiraldi, M. D. Colombo, S. Harari, S. Lo Cicero, G. Ziglio, M. Ferrarese, D. Rossato & E. Soresi. (1996) Terbinafine in the treatment of non-immunocompromised compassionate cases of bronchopulmonary aspergillosis. Mycoses 39:1-2, pages 5-12.
Crossref
George deStevens, V. Zingel, C. Leschke, W. Schunack, Paul D. Hoeprich, Richard M. Schultz, P. K. Mehrotra, Sanjay Batra, A. P. Bhaduri, Anil K. Saxena & Mridula SaxenaPaul D. Hoeprich. 1995. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques 87 127 .
T VagoG BaldiD ColomboM BarbareschiG NorbiatoF DallegriM Bevilacqua. (1994) Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 38:11, pages 2605-2611.
Crossref
Morio Yamada, Takashi Nishigami, Keiji Nakasho, Yukiyasu Nishimoto & Hideki Miyaji. (1994) Relationship between Sigma-like site and progesterone-binding site of adult male rat liver microsomes. Hepatology 20:5, pages 1271-1280.
Crossref
Edgar B. Smith. (1993) Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis. Journal of the American Academy of Dermatology 28:5, pages S24-S28.
Crossref
M.J.D. GOODFIELD. (1992) Short-duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trial. British Journal of Dermatology 126:s39, pages 33-35.
Crossref
D.J. BACK, J.F. TJIA & S.M. ABEL. (1992) Azoles, a48 llylamines and drug metabolism. British Journal of Dermatology 126:s39, pages 14-18.
Crossref
N.S. RYDER. (1992) Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. British Journal of Dermatology 126:s39, pages 2-7.
Crossref
Neil S. Ryder & Hubert Mieth. 1992. Current Topics in Medical Mycology. Current Topics in Medical Mycology 158 188 .
DJ Back & JF Tjia. (1991) Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.. British Journal of Clinical Pharmacology 32:5, pages 624-626.
Crossref
Peter Nussbaumer, Neil S. Ryder & Anton Stütz. (2006) Allylamine antimycotics: Recent trends in structure—activity relationships and syntheses. Pesticide Science 31:4, pages 437-455.
Crossref
Jay E. Birnbaum. (1990) Pharmacology of the allylamines. Journal of the American Academy of Dermatology 23:4, pages 782-785.
Crossref
Gerard D. Wright, Todd Parent & John F. Honek. (1990) Non-sterol structural probes of the lanosterol 14α-demethylase from Saccharomyces cerevisiae. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1040:1, pages 95-101.
Crossref
Thomas C. Jones & Violette V. Villars. 1990. Chemotherapy of Fungal Diseases. Chemotherapy of Fungal Diseases 483 503 .
Michael H. Tarbit, William R. Robertson & Ann Lambert. 1990. Chemotherapy of Fungal Diseases. Chemotherapy of Fungal Diseases 205 229 .
N. S. Ryder. 1990. Biochemistry of Cell Walls and Membranes in Fungi. Biochemistry of Cell Walls and Membranes in Fungi 189 203 .
Yuzo Yoshida & Yuri Aoyama. (2004) Stereoselective interaction of an azole antifungal agent with its target, lanosterol 14α‐demethylase (cytochrome p ‐450 14dm ): A model study with stereoisomers of triadimenol and purified cytochrome p ‐450 14dm from yeast . Chirality 2:1, pages 10-15.
Crossref
DJ Back, P. Stevenson & JF Tjia. (1989) Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.. British Journal of Clinical Pharmacology 28:2, pages 166-170.
Crossref
N. ZAIAS & L. SERRANO. (1989) The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine. Clinical and Experimental Dermatology 14:2, pages 120-123.
Crossref
R. SAVIN. (1989) Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil). Clinical and Experimental Dermatology 14:2, pages 116-119.
Crossref
N.S. RYDER. (1989) The mechanism of action of terbinafine. Clinical and Experimental Dermatology 14:2, pages 98-100.
Crossref
A. Wahll�nder & G. Paumgartner. (1989) Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers. European Journal of Clinical Pharmacology 37:3, pages 279-283.
Crossref
R. Seyffer, M. Eichelbaum, J. C. Jensen & U. Klotz. (1989) Antipyrine metabolism is not affected by terbinafine, a new antifungal agent. European Journal of Clinical Pharmacology 37:3, pages 231-233.
Crossref
Paul J. Kuhn. (2006) The discovery and development of fungicides—does biochemistry have a role?. Pesticide Science 25:2, pages 123-135.
Crossref
KEITH BARRETT‐BEE, JOYCE LEES, PHILIP PINDER, JULIE CAMPBELL & LORRAINE NEWBOULT. (2006) Biochemical Studies with a Novel Antifungal Agent, ICI 195,739. Annals of the New York Academy of Sciences 544:1, pages 231-244.
Crossref
NEIL S. RYDER. (2006) Mechanism of Action and Biochemical Selectivity of Allylamine Antimycotic Agents. Annals of the New York Academy of Sciences 544:1, pages 208-220.
Crossref
ANTON STÜTZ. (2006) Synthesis and Structure‐ Activity Correlations within Allylamine Antimycotics. Annals of the New York Academy of Sciences 544:1, pages 46-62.
Crossref
Markku Pasanen, Taina Taskinen, Mumtaz Iscan, Eero A. Sotaniemi, Matti Kairaluoma & Olavi Pelkonen. (1988) Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics. Biochemical Pharmacology 37:20, pages 3861-3866.
Crossref
J.Brian Houston, Michael J. Humphrey, Diana E. Matthew & Michael H. Tarbit. (1988) Comparison of two azole antifungal drugs, ketoconazole and fluconazole, as modifiers of rat hepatic monooxygenase activity. Biochemical Pharmacology 37:3, pages 401-408.
Crossref
Larry E. Millikan, Wesley K. Galen, Garry B. Gewirtzman, Stephen N. Horwitz, R. Kenneth Landow, Lee T. NesbittJr.Jr., Harry L. Roth, John Sefton & Robert M. Day. (1988) Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis. Journal of the American Academy of Dermatology 18:1, pages 52-56.
Crossref
D.S. Senior & J.T.B. Shaw. (1988) In vitro effects of fluconazole (UK-49, 858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes. International Journal of Immunopharmacology 10:2, pages 169-173.
Crossref
A.D. Rodrigues, G.G. Gibson, C. Ioannides & D.V. Parke. (1987) Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochemical Pharmacology 36:24, pages 4277-4281.
Crossref
Paul J. Boor & Robert M. Hysmith. (1987) Allylamine cardiovascular toxicity. Toxicology 44:2, pages 129-145.
Crossref
Anton Stütz. (1987) Allylamin-Derivate – eine neue Wirkstoffklasse in der antifungalen Chemotherapie. Angewandte Chemie 99:4, pages 323-331.
Crossref
Thomas F. Woolf & Ronald A. Jordan. (2013) Basic Concepts in Drug Metabolism: Part I. The Journal of Clinical Pharmacology 27:1, pages 15-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.